Startups
Lucius Partners
Edit

Lucius Partners

https://luciuspartners.com/
Last activity: 22.07.2025
Probably Closed
Categories: BusinessDevelopmentDiagnosticsFinTechGrowthHardwareLifeManagementMedtechScience
ADVANCING BUSINESSES WITH A SIMPLE APPROACH LUCIUS PARTNERS PROVIDE SKILLS AND EXPERIENCE TO CREATE AN ENVIRONMENT FOR RAPID GROWTH Lucius Partners is currently invested in four life science portfolio companies and are constantly searching for new scientific opportunities in areas of high unmet need. Our investment lens is not limited to just one therapeutic area or scientific field. We look for areas of unmet need ranging from vaccines and therapeutics to diagnostics and medical devices. We create the financial roadmap driven by critical milestone delivery. But that is just the start. We provide operational focus and expertise on critical success factors that will rapidly advance early science projects into life science development companies. The team’s skills and experiences are leveraged across the portfolio to ensure these small companies get the power and knowledge often only seen in larger companies. Lucius Partners works with the management teams to identify key development initiatives and to optimize our collective success. Lucius Partners and their Advisors have experience that matters as well as the connections to advance businesses quickly. The wide array of experience includes: Financing and investment banking Establishing companies Establishing companies Capital structuring including public and private funding Drug and device development Clinical operations management Regulatory relations and approvals Business Development Commercial Assessment
Followers
11
Mentions
2

Overview

Location
United States, New York
Employees
11-50

Mentions in press and media 2

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Apr 7, 2025Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private PlacementFunding expected to support first clinical trial of APTN-101 for the treatment of glioblastoma CHARLOTTE, N.C., April 07, 2025 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (“Adaptin” or the “Company”), a biotechnology company focused on developing...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Lucius Partners

What has the press written about Lucius Partners?

Parsers VC has collected 2 articles mentioning Lucius Partners, among them “Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement” (Apr 7, 2025).

Is Lucius Partners still active?

Lucius Partners is probably closed: its latest activity on Parsers VC dates from Jul 22, 2025.